A recent study from the University of Hong Kong suggests that a newer type of diabetes drug, called sodium-glucose cotransporter 2 inhibitors (SGLT2i), may help protect the kidneys and lungs in people ...
It’s important for the scientists to be empowered to do the science and the policymakers to do the policy, and for all of us to collaborate and work together,” Zeldin said.